Regulations/FDA CSA/Source Library
Source Library · FDA CSA

Source Library for FDA CSA.

This source library keeps official references, implementation status, and public-use boundaries visible for the workspace. It supports evidence-readiness without turning protected standards, guidance, or legal material into loose checklist language.

Source basis: Computer Software Assurance for Production and Quality System SoftwareUse: evidence-readinessBoundary: not legal advice
FDA CSA TRACE FDA CSA FINAL GUIDQMSR TERMINOLOGYPRODUCTION SOFTWQUALITY MANAGEME
/ Source discipline

What can be used publicly and what must stay bounded.

public-safe
Rule 01

Official source first

Use regulator, source-owner, EUR-Lex, FDA, EMA, ICH, ISO/IEC, ISPE, IMDRF, Health Canada, MHRA or similar authority/source-owner pages before commentary.

Rule 02

Paid-source boundary

Where a standard or guide is protected, the page names the source and describes public-safe implications without reproducing protected clause text.

Rule 03

Status visible

Every source needs date/status language so draft, final, watch item, and effective/applicable dates are not mixed.

Rule 04

Interpretation separated

Source fact and iFeed interpretation must remain visibly separated before any checklist is published.

/ Source objects

Objects that deserve stable child pages.

future expansion
Object 01

FDA CSA final guidance

Primary source for risk-based assurance of production and quality management system software.

Object 02

QMSR terminology revision

February 2026 revisions aligned CSA language with QMSR terminology.

Object 03

Production software scope

Manufacturing, inspection, automation, and production controls can be in scope.

Object 04

Quality management system software scope

eQMS, CAPA, complaint, supplier, document, and record systems may need CSA reasoning.

Object 05

Objective evidence

Records should show what assurance activity happened and why it was adequate.

Object 06

Unscripted testing

Can be appropriate when justified by intended use and risk.